Clinical Trials Browser

Phase 2 × Neuroma, Acoustic × 1 year × Clear all

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Phase 2 Active not recruiting

97 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01199978 2025-10-01

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Phase 2 Active not recruiting

30 enrolled

CNS

Neuroma, Acoustic

Clinical Trials

INTUITT-NF2

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Study of Aspirin in Patients With Vestibular Schwannoma

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma